Literature DB >> 2785954

The murine cellular immune response to adenovirus type 5.

A Müllbacher1, A J Bellett, R T Hla.   

Abstract

We have characterized the cellular immune response to human adenovirus 5 (Ad-5) in mice, as a basis for future study of responses to foreign antigens in recombinant adenoviruses. Primary in vivo lytic effector cells contained both virus immune cytolytic T (Tc) cells and natural killer cells. The Tc effectors could be boosted in vitro to give a secondary Tc cell response. The Tc cell response to Ad-5 was major histocompatibility complex (MHC) restricted, and in CBA/H (H-2k) mice mapped to the K end of MHC. Kinetic experiments suggested the Tc cell response was directed against early rather than late viral proteins. Experiments with viral mutants showed that the main responses were to the E1A and E1B proteins, with some involvement of E2. Expression of E3 and E4 in infected targets was not required, in fact lysis of target cells infected by viruses with a deletion in E3 was augmented.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785954     DOI: 10.1038/icb.1989.4

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  10 in total

1.  Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.

Authors:  T E Sparer; S G Wynn; D J Clark; J M Kaplan; L M Cardoza; S C Wadsworth; A E Smith; L R Gooding
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  A single gene encoding the fiber is responsible for variations in virulence in the fowl adenoviruses.

Authors:  J Pallister; P J Wright; M Sheppard
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ.

Authors:  G Wolff; S Worgall; N van Rooijen; W R Song; B G Harvey; R G Crystal
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.

Authors:  Y Yang; Q Li; H C Ertl; J M Wilson
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  Increased sensitivity to staphylococcal enterotoxin B following adenoviral infection.

Authors:  Timur O Yarovinsky; Michael P Mohning; Mary A Bradford; Martha M Monick; Gary W Hunninghake
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Anti-adenovirus type 5 cytotoxic T lymphocytes: immunodominant epitopes are encoded by the E1A gene.

Authors:  J M Routes; D Bellgrau; W J McGrory; D S Bautista; F L Graham; J L Cook
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.

Authors:  K Jooss; H C Ertl; J M Wilson
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 8.  Gene therapy for phenylketonuria.

Authors:  R C Eisensmith; S L Woo
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy.

Authors:  Ann M Leen; Anne Christin; Mariam Khalil; Heidi Weiss; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Catherine M Bollard
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

10.  Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.

Authors:  C A Smith; L S Woodruff; G R Kitchingman; C M Rooney
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.